-+ 0.00%
-+ 0.00%
-+ 0.00%

U.S. FDA APPROVES NUZOLVENCE® (ZOLIFLODACIN), A FIRST-IN-CLASS, SINGLE-DOSE, ORAL ANTIBIOTIC FOR THE TREATMENT OF UNCOMPLICATED UROGENITAL GONORRHEA IN ADULTS AND ADOLESCENTS

路透·12/12/2025 21:56:00

登錄查看新聞詳情